OncogeneCancer BiologyPeer-reviewed journal article
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pigmentation pathway
A. Swoboda, R. Soukup, K. Kinslechner, B. Wingelhofer, D. Schoerghofer, C. Sternberg, H. Pham, M. Vallianou, J. Horvath, D. Stoiber, L. Kenner, L. Larue, V. Poli, F. Beermann, T. Yokota, S. Kubicek, T. Krausgruber, A. Rendeiro, C. Bock, R. Zenz, B. Kovacic, F. Aberger, M. Hengstschlaeger, P. Petzelbauer, M. Mikula, R. Moriggl
Abstract
Metastatic melanoma is hallmarked by its ability to switch oncogenic MITF expression. Here we tested the impact of STAT3 on melanoma onset and progression in association with MITF expression levels. We established a mouse melanoma model for deleting Stat3 specifically in melanocytes with specific expression of human hyperactive NRASQ61K in an Ink4a deficient background. Mice with tissue specific Stat3 deletion showed an early onset of disease, but displayed significantly diminished lung metastases. Whole genome expression profiling also revealed a reduced invasion phenotype, which was functionally confirmed in 3D melanoma model systems. Notably, loss or knockdown of STAT3 in mouse or human cells resulted in up-regulation of MITF and induction of cell proliferation. Mechanistically we show that STAT3 induced CEBPa/b expression was sufficient to suppress MITF transcription. Epigenetic analysis by ATAC-seq confirmed that STAT3 enabled CEBPa/b binding to the MITF enhancer region thereby silencing it. We conclude that STAT3 is a metastasis driver in melanoma able to antagonize the MITF oncogene via direct induction of CEBP family member transcription facilitating RAS-RAF-driven melanoma metastasis.\n\nList of Abbreviations\n\nATAC-seq, Assay for Transposase-Accessible Chromatin using sequencing; CEBP, CAAT Box Enhancer Binding Protein; CRE, Cre recombinase; EGF, Epidermal Growth Factor; GEO, Gene Expression Omnibus; GSEA, Gene Set Enrichment Analysis; HSC70, Heat Shock 70 kDa protein; IHC, Immunohistochemistry; IL-6, Interleukin-6; JAK, Janus Kinase; MITF, Microphthalmia-Associated Transcription Factor; NSG, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice; OSM, Oncostatin M; PDGF, Platelet-Derived Growth Factor; pS, phosphoserine; pY, phosphotyrosine; RAS, Rat Sarcoma; RAF, Rapidly Accelerated Fibrosarcoma; RTK, Receptor Tyrosine Kinase; RT-PCR, Reverse Transcription Polymerase Chain Reaction; S100b, Calcium Binding Protein S100 beta; shRNA, short hairpin RNA; SOX10, Sex Determining Region Y-10; STAT, Signal Transducer and Activator of Transcription; TCGA, The Cancer Genome Atlas; TMA, Tissue Micro Array
- organism: mouse
- assay: ATAC-seq
- research focus: cell signaling & trafficking
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The small MAF transcription factor MAFG co-opts MITF to promote melanoma progression
Olga Vera, Michael Martinez, … Florian A. Karreth·Nature CommunicationsPeer-reviewed·May 21, 2026
- Antagonistic Roles for MITF and TFE3 in Melanoma Plasticity
Jeremy Chang, Katelyn R. Campbell-Hanson, … Colin Kenny·Cell ReportsPeer-reviewed·Mar 26, 2025
- SATB2 induction of a neural crest mesenchyme-like program drives invasion and drug resistance in melanoma
M. Fazio, E. van Rooijen, … L. I. Zon·bioRxiv·Nov 1, 2020
- HDAC8-mediated inhibition of EP300 drives a neural crest-like transcriptional state that increases melanoma brain metastasis
M. F. Emmons, R. L. Bennett, … K. S. M. Smalley·bioRxiv·Oct 12, 2022
- Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity
Kévin Berthenet, Serena Diazzi, … Gabriel Ichim·Cell Death and DiseasePeer-reviewed·Oct 6, 2025
- Mechanisms underlying melanoma invasion as a consequence of MLK3 loss
H. Balinda, A. Sedgwick, C. D'Souza-Schorey·bioRxiv·Dec 10, 2021